Jane Street’s ADMA Biologics ADMA Stock Holding History

Jane Street’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$183K	Sell	20,300 -41,900	-67%	-$661K	﹤0.01%	10235
2025 Q4	$1.13M	Sell	62,200 -90,400	-59%	-$1.52M	﹤0.01%	5865
2025 Q3	$2.24M	Buy	152,600 +101,300	+197%	+$1.74M	﹤0.01%	4735
2025 Q2	$934K	Buy	51,300 +18,000	+54%	+$367K	﹤0.01%	5743
2025 Q1	$661K	Buy	+33,300	New	+$576K	﹤0.01%	6352
2023 Q3	–	Sell	-53,400	Closed	-$197K	–	8535
2023 Q2	$197K	Buy	53,400 +1,200	+2%	+$4.45K	﹤0.01%	7687
2023 Q1	$173K	Buy	+52,200	New	+$180K	﹤0.01%	7936
2022 Q1	–	Sell	-22,700	Closed	-$32K	–	10189
2021 Q4	$32K	Buy	22,700 +2,300	+11%	+$3.02K	﹤0.01%	9676
2021 Q3	$23K	Buy	20,400 +2,100	+11%	+$2.94K	﹤0.01%	9730
2021 Q2	$29K	Buy	+18,300	New	+$32.2K	﹤0.01%	9598

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jane Street's ADMA Position: Q1 2026 in Review

Jane Street increased its ADMA Biologics (ADMA) stake by 564% in Q1 2026, buying an estimated $40.9M and bringing the position to 3,051,943 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Jane Street first reported a position in ADMA in Q1 2019 and has held it in 25 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

Jane Street held 3,051,943 shares of ADMA Biologics worth $27.5M as of Q1 2026.
Jane Street bought 2,592,519 ADMA Biologics shares in Q1 2026, an estimated $40.9M.
ADMA Biologics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1510 holding.
Jane Street first reported a position in ADMA Biologics in Q1 2019 and has held it in 25 quarters since.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.